Most Recent
Firm’s fees in Boston Scientific class action OK’d, 8 months after settlement gets nod
A judge has signed off on almost $7.5 million in fees billed by the law firm behind the pelvic mesh class action against Boston Scientific, eight months after he approved the device maker's $105 million settlement.
CBA reaches settlement in 7-year-old class action by borrowers
A protracted class action against the Commonwealth Bank of Australia brought by borrowers who claimed they were forced to default on their commercial loans has finally settled, a court has heard. 
Bruce Lehrmann admits he bought Brittany Higgins drinks on night of alleged rape
Former Liberal staffer Bruce Lehrmann has walked back evidence in his defamation trial that he did not buy Brittany Higgins any alcoholic drinks on the night he allegedly raped her, saying he “must have been confused”.
ASIC dodges indemnity costs for ‘unreasonable’ rejection of settlement in case against liquidator
ASIC has escaped an individual insolvency practitioner’s bid for indemnity costs in its failed case alleging illegal phoenix activity, with a judge finding the regulator did not unreasonably reject a settlement offer that would have netted it “a considerably better result” than it won at trial.
AMP to pay $100M to settle BOLR class action
AMP has agreed to pay $100 million to settle a class action by financial advisers over its buyer of last resort policy, after suffering a loss at trial.
Phoney Airtasker lawyer wins three-month cut to sentence on appeal
A judge has reduced the jail sentence imposed on a Brisbane man who falsely represented he was a lawyer on the Airtasker app, but refused his bid to get away with a fine, saying a prison term “was the only appropriate sentencing option” in the case.
United class action wants to add commission agents, join parent company
A franchise class action against United Petroleum has asked a court for leave to expand the class action to include a group of commission agents and to add the oil company's parent as a third defendant.
Sandoz tries again to invalidate Xarelto patents
Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and failed to revoke two Bayer patents for the drug.
Aveo’s $11M class action settlement OK’d, but ‘avoidable costs’ yet to be doled out
A judge has given the green light to a $11 million settlement in a class action against retirement village provider Aveo, but reserved his decision about whether a contested amount of over $1 million should go to group members or the law firm that brought the case.